Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C32H37NO13 |
Molecular Weight | 643.6351 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]1(C[C@H](N)[C@H](O)[C@H](C)O1)O[C@H]2[C@@H](O)C[C@]([H])(O[C@H]3C[C@@](O)(CC4=C(O)C5=C(C(=O)C6=CC=CC=C6C5=O)C(O)=C34)C(=O)CO)O[C@H]2C
InChI
InChIKey=VQHRZZISQVWPLK-UIRGBLDSSA-N
InChI=1S/C32H37NO13/c1-12-26(37)17(33)7-21(43-12)46-31-13(2)44-22(8-18(31)35)45-19-10-32(42,20(36)11-34)9-16-23(19)30(41)25-24(29(16)40)27(38)14-5-3-4-6-15(14)28(25)39/h3-6,12-13,17-19,21-22,26,31,34-35,37,40-42H,7-11,33H2,1-2H3/t12-,13-,17-,18-,19-,21-,22-,26+,31+,32-/m0/s1
Molecular Formula | C32H37NO13 |
Molecular Weight | 643.6351 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Sabarubicin (previously known as MEN-10755), a disaccharide analog of doxorubicin that was developed by Menarini Pharmaceuticals for the treatment of solid tumors, including small cell lung cancer and prostate cancer. Sabarubicin exhibits a superior antitumor efficacy, presumably related to the activation of p53-independent apoptosis. The drug participated in phase II clinical trials to study its effectiveness in treating patients who have progressive prostate cancer that has not responded to hormone therapy and in chemotherapy-naive patients with extensive stage small cell lung cancer. On 21 December 2004, the European Commission granted the orphan designation to Menarini for sabarubicin for the treatment of small cell lung cancer.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart. | 2000 Sep |
|
Sabarubicin (MEN10755)-induced apoptosis is independent from mtDNA in A2780 human ovarian tumor cells. | 2007 Nov-Dec |
|
Sabarubicin. | 2008 |
|
Interaction between double helix DNA fragments and the new antitumor agent sabarubicin, Men10755. | 2010 Feb 15 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:10:40 GMT 2023
by
admin
on
Fri Dec 15 16:10:40 GMT 2023
|
Record UNII |
XS499WOZ93
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1594
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/04/255
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000124427
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
DB12410
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
XS499WOZ93
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
CHEMBL591251
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
C107602
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
Sabarubicin
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
DTXSID30870233
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
211100-13-9
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
C1706
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
SUB32245
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
8396
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY | |||
|
151897
Created by
admin on Fri Dec 15 16:10:40 GMT 2023 , Edited by admin on Fri Dec 15 16:10:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |